Risk Adaptive Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer
Journal Title: Üroonkoloji Bülteni - Year 2017, Vol 16, Issue 2
Abstract
Muscle invasive bladder cancer (MIBC) is an aggressive tumor with a high rate of early systemic dissemination. The main treatment for MIBC is still radical cystectomy and lymph node dissection. Survival rates for 5-year are 70-80% for organ-confined disease and 20-30% for extravesical disease. Although surgery provides excellent control for organ-confined bladder cancer, recurrences are common in surgery alone. Therefore, it is important to treat micrometastatic disease with perioperative chemotherapy. Although there are grade 1 evidences for use of cisplatin-based neoadjuvant chemotherapy (NAC), utilization of NAC rates are still very low all over the world. Thus, approaches trying to determine the selection of appropriate patients for NAC were investigated. High-risk groups to benefit from NAC includes palpable mass in the detection under anesthesia before surgery, clinical T3 or T4a disease, hydronephrosis, lymphovascular invasion and aggressive variant histology. Risk adaptive approaches based on clinicopathologic parameters may increase the rate of benefit from NAC until routine usage of molecular markers and methods that can detect micrometastatic disease.
Authors and Affiliations
Elif Atağ, Aziz Karaoğlu, Ömer Küçük
Evaluation of Testicular Self-examination Technique and Testis Cancer Knowledge Levels of Final-year Medical Students
Objective: The aim of this study was to evaluate the adequacy of knowledge regarding testicular self-examination (TSE) in final-year medical students and determine the TSE performance rate among male students. Materials...
The Relationship between Bladder Cancer and Epigenetic Alterations
Bladder cancer is one of the most common cancers of urinary system and approximately 70% of the cases are low grade and non-muscle invasive. Because of the histological indicator inadequacy of heterogeneous tumors like b...
Predictive Value of Hormonal Evaluation Before Prostate Needle Biopsy on Prostate Cancer T Stage and Prognosis
Objective: In this study we evaluated the hormone data before prostate needle biopsy (PNB) in patients who underwent retropubic radical prostatectomy (RRP) due to prostate adenocarcinoma (PCa). Correlations between the p...
Determination of Six Transmembrane Protein of Prostate 2 Gene Expression and Intracellular Localization in Prostate Cancer
Objective In this study, we aimed to determine the relationship between the RNA and protein expression profile of six transmembrane protein of prostate 2 (STAMP2) gene and androgen and the intracellular localization of...
Wunderlich Syndrome, Tuberous Sclerosis-Related Giant Renal Angiomyolipoma Rupture: Case Report
Angiomyolipoma (AML) is a mesenchymal tumor of the kidney that is composed of morphologically abnormal smooth muscle cells, blood vessels, and adipose-like foci. Renal AML is usually clinically asymptomatic and detected...